Stocksigma LogoStocksigma Logo

RPG Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 21,164 (+16.5% YoY | +8.2% QoQ) ■ EBITDA: 4,042 (+3.6% YoY | -7.3% QoQ) ■ EBITDA Margin (%): 19.1 (-238 bps YoY | -318 bps QoQ) ■ PAT: 2,660

RPG Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

RPG Life Sciences Ltd · Outcome · 30 Oct 2026, 3:07 am

RPG Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 21,164 (+16.5% YoY | +8.2% QoQ) ■ EBITDA: 4,042 (+3.6% YoY | -7.3% QoQ) ■ EBITDA Margin (%): 19.1 (-238 bps YoY | -318 bps QoQ) ■ PAT: 2,660 (-27.8% YoY | -13.0% QoQ) ■ EPS (INR): 17.1 (-23.4% YoY | -7.7% QoQ)

Original exchange filing (PDF)

More announcements from RPG Life Sciences Ltd

All RPG Life Sciences Ltd announcements